Exploring Metabolic Profile Differences between Colorectal Polyp Patients and Controls Using Seemingly Unrelated Regression
- PMID: 25919433
- PMCID: PMC4729298
- DOI: 10.1021/acs.jproteome.5b00059
Exploring Metabolic Profile Differences between Colorectal Polyp Patients and Controls Using Seemingly Unrelated Regression
Abstract
Despite the fact that colorectal cancer (CRC) is one of the most prevalent and deadly cancers in the world, the development of improved and robust biomarkers to enable screening, surveillance, and therapy monitoring of CRC continues to be evasive. In particular, patients with colon polyps are at higher risk of developing colon cancer; however, noninvasive methods to identify these patients suffer from poor performance. In consideration of the challenges involved in identifying metabolite biomarkers in individuals with high risk for colon cancer, we have investigated NMR-based metabolite profiling in combination with numerous demographic parameters to investigate the ability of serum metabolites to differentiate polyp patients from healthy subjects. We also investigated the effect of disease risk on different groups of biologically related metabolites. A powerful statistical approach, seemingly unrelated regression (SUR), was used to model the correlated levels of metabolites in the same biological group. The metabolites were found to be significantly affected by demographic covariates such as gender, BMI, BMI(2), and smoking status. After accounting for the effects of the confounding factors, we then investigated potential of metabolites from serum to differentiate patients with polyps and age matched healthy controls. Our results showed that while only valine was slightly associated, individually, with polyp patients, a number of biologically related groups of metabolites were significantly associated with polyps. These results may explain some of the challenges and promise a novel avenue for future metabolite profiling methodologies.
Keywords: NMR spectroscopy; colorectal polyp; metabolic profiling; metabolomics; seemingly unrelated regression.
Figures
Similar articles
-
Altered metabolite levels and correlations in patients with colorectal cancer and polyps detected using seemingly unrelated regression analysis.Metabolomics. 2017 Nov;13(11):125. doi: 10.1007/s11306-017-1265-0. Epub 2017 Sep 15. Metabolomics. 2017. PMID: 30814918 Free PMC article.
-
Colorectal cancer detection using targeted serum metabolic profiling.J Proteome Res. 2014 Sep 5;13(9):4120-30. doi: 10.1021/pr500494u. Epub 2014 Aug 15. J Proteome Res. 2014. PMID: 25126899
-
Global and targeted serum metabolic profiling of colorectal cancer progression.Cancer. 2017 Oct 15;123(20):4066-4074. doi: 10.1002/cncr.30829. Epub 2017 Jun 22. Cancer. 2017. PMID: 28640361 Free PMC article.
-
Translational Metabolomics of Head Injury: Exploring Dysfunctional Cerebral Metabolism with Ex Vivo NMR Spectroscopy-Based Metabolite Quantification.In: Kobeissy FH, editor. Brain Neurotrauma: Molecular, Neuropsychological, and Rehabilitation Aspects. Boca Raton (FL): CRC Press/Taylor & Francis; 2015. Chapter 25. In: Kobeissy FH, editor. Brain Neurotrauma: Molecular, Neuropsychological, and Rehabilitation Aspects. Boca Raton (FL): CRC Press/Taylor & Francis; 2015. Chapter 25. PMID: 26269925 Free Books & Documents. Review.
-
Surveillance of colonic polyps: Are we getting it right?World J Gastroenterol. 2016 Feb 14;22(6):1925-34. doi: 10.3748/wjg.v22.i6.1925. World J Gastroenterol. 2016. PMID: 26877600 Free PMC article. Review.
Cited by
-
Globally Optimized Targeted Mass Spectrometry: Reliable Metabolomics Analysis with Broad Coverage.Anal Chem. 2015 Dec 15;87(24):12355-62. doi: 10.1021/acs.analchem.5b03812. Epub 2015 Dec 2. Anal Chem. 2015. PMID: 26579731 Free PMC article.
-
Demographic, Health and Lifestyle Factors Associated with the Metabolome in Older Women.Metabolites. 2023 Apr 3;13(4):514. doi: 10.3390/metabo13040514. Metabolites. 2023. PMID: 37110172 Free PMC article.
-
Integrative analysis of time course metabolic data and biomarker discovery.BMC Bioinformatics. 2020 Jan 9;21(1):11. doi: 10.1186/s12859-019-3333-0. BMC Bioinformatics. 2020. PMID: 31918658 Free PMC article.
-
Altered metabolite levels and correlations in patients with colorectal cancer and polyps detected using seemingly unrelated regression analysis.Metabolomics. 2017 Nov;13(11):125. doi: 10.1007/s11306-017-1265-0. Epub 2017 Sep 15. Metabolomics. 2017. PMID: 30814918 Free PMC article.
-
Serum Colorectal Cancer Biomarkers Unraveled by NMR Metabolomics: Past, Present, and Future.Anal Chem. 2022 Jan 11;94(1):417-430. doi: 10.1021/acs.analchem.1c04360. Epub 2021 Nov 22. Anal Chem. 2022. PMID: 34806875 Free PMC article. No abstract available.
References
-
- Weitz J, Koch M, Debus J, Höhler T, Galle PR, Büchler MW. Colorectal cancer. Lancet. 2005;365(9454):153–165. - PubMed
-
- Siegel R, Miller KD, Jemal A. Cancer statistics, 2015. CA— Cancer J. Clin. 2015;65(1):5–29. - PubMed
-
- Rex DK, Johnson DA, Anderson JC, Schoenfeld PS, Burke CA, Inadomi JM. American college of gastroenterology guidelines for colorectal cancer screening 2008. Am. J. Gastroenterol. 2009;104(3):739–750. - PubMed
-
- Stegeman I, de Wijkerslooth TR, Mallant-Hent RC, de Groot K, Stroobants AK, Fockens P, Mundt M, Bossuyt PM, Dekker E. Implementation of population screening for colorectal cancer by repeated Fecal Immunochemical Test (FIT): third round. BMC Gastroenterol. 2012:12–73. - PMC - PubMed
- Imperiale TF, Ransohoff DF, Itzkowitz SH, Levin TR, Lavin P, Lidgard GP, Ahlquist DA, Berger BM. Multitarget stool DNA testing for colorectal-cancer screening. N. Engl. J. Med. 2014;370(4):1287–1297. - PubMed
-
- Taylor DP, Cannon-Albright LA, Sweeney C, Williams MS, Haug PJ, Mitchell JA, Burt RW. Comparison of compliancefor colorectal cancer screening and surveillance by colonoscopy based on risk. Genet. Med. 2011;13(8):737–743. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical